![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905013/0/en/Nkarta-Initiates-Clinical-Trial-of-NKX019-in-Lupus-Nephritis-with-First-Patient-in-Screening-and-Announces-Pipeline-Expansion-to-Additional-Autoimmune-Indications.html
https://www.globenewswire.com/news-release/2024/06/13/2898623/0/en/Nkarta-Adds-Experienced-Leader-in-Autoimmune-R-D-George-Vratsanos-M-D-FACR-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/05/09/2879118/0/en/Nkarta-Reports-First-Quarter-2024-Financial-Results-and-Corporate-Highlights.html
https://www.globenewswire.com/news-release/2024/03/25/2851470/0/en/Nkarta-Announces-Pricing-of-240-Million-Underwritten-Offering.html
https://www.fiercebiotech.com/biotech/nkartas-blood-cancer-car-stalls-again-falling-response-rate-forcing-it-out-race
https://www.globenewswire.com/news-release/2024/03/21/2850602/0/en/Nkarta-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Highlights.html
https://www.globenewswire.com//news-release/2023/12/10/2793454/0/en/Nkarta-Presents-NKX101-Clinical-Data-at-the-2023-American-Society-of-Hematology-Annual-Meeting-Exposition.html
https://www.globenewswire.com//news-release/2023/11/07/2775080/0/en/Nkarta-to-Participate-at-Upcoming-Investor-Conferences.html
https://www.fiercebiotech.com/biotech/nkartas-stock-soars-112-after-fda-clears-lupus-trial-assessing-cell-therapy
https://endpts.com/nkarta-trims-headcount-as-it-sets-sights-on-autoimmune-cell-therapy/